Campaigners’ drug deal hope

A deal needs to be struck on access to a key breast cancer drug in Scotland to give women “more time to live”, campaigners have warned.

The Scottish Government has revealed its officials and the NHS are in talks with the manufacturer of breast cancer drug Perjeta, which has been rejected three times for routine use on the NHS in Scotland but is available south of the border.

Charity Breast Cancer Now said the drug can prolong the lives of women with incurable HER2 positive metastatic breast cancer by up to 16 months.

The charity is calling for a deal to be struck “fast”.